Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CHILDREN'S TYLENOL FEVER & SORE THROAT PAIN - Health Canada Drug Approval Details

Approvals/Health Canada/CHILDREN'S TYLENOL FEVER & SORE THROAT PAIN

Authorized

STANDARD

CHILDREN'S TYLENOL FEVER & SORE THROAT PAIN

mcneil consumer healthcare division of johnson & johnson inc🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 8d35fefc31f0e698
Company: mcneil consumer healthcare division of johnson & johnson inc
Type: Standard

Approval Details

Approval Id: 8d35fefc31f0e698
Drug Approval Canada Name: CHILDREN'S TYLENOL FEVER & SORE THROAT PAIN
Product Name: CHILDREN'S TYLENOL FEVER & SORE THROAT PAIN
Status: Marketed
Status Date: 2018-05-28
Original Market Date: 2018-05-28
Din: 02389924
Drug Class: Human
Dosage Form: Suspension
Route Of Administration: Oral
Schedule: OTC
Ahfs: 28:08.92
Atc Original: N02BE01 ACETAMINOPHEN (PARACETAMOL)
Atc Name: n 02 be 01
Aig Number: 0102009005
Company Name: mcneil consumer healthcare division of johnson & johnson inc
Company Address: 88 Mcnabb Street, Markham, Ontario, Canada, L3R 5L2

Active Ingredients

ACETAMINOPHEN

160 MG / 5 ML

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

8d35fefc31f0e698

Type

Standard

Back to Health Canada Approvals